Acura Pharmaceuticals Engages Catalent Pharma Solutions to Advance Development of LTX-03
09 sept. 2019 06h00 HE
|
Acura Pharmaceuticals, Inc.
PALATINE, Ill., Sept. 09, 2019 (GLOBE NEWSWIRE) -- Acura Pharmaceuticals, Inc. (OTC Pink: ACUR), today announced that it has engaged Catalent Pharma Solutions, LLC (“Catalent”) to initiate...
Acura Pharmaceuticals Licenses LIMITx™ LTX-03
02 juil. 2019 16h30 HE
|
Acura Pharmaceuticals, Inc.
Agreement Provides For Completion of Development and CommercializationTransaction Valued at up to $21.3 Million, not including Royalties PALATINE, Ill., July 02, 2019 (GLOBE NEWSWIRE) -- Acura...
Acura Pharmaceuticals Announces Third Quarter 2018 Financial Results
27 nov. 2018 16h15 HE
|
Acura Pharmaceuticals, Inc.
PALATINE, Ill., Nov. 27, 2018 (GLOBE NEWSWIRE) -- Acura Pharmaceuticals, Inc. (OTCQB: ACUR), a specialty pharmaceutical company innovating abuse deterrent drugs, announced today financial results...
Acura Pharmaceuticals, Inc. Restructures Debt Obligations
09 oct. 2018 16h15 HE
|
Acura Pharmaceuticals, Inc.
PALATINE, Ill., Oct. 09, 2018 (GLOBE NEWSWIRE) -- Acura Pharmaceuticals, Inc. (OTCQB: ACUR), a specialty pharmaceutical company focused on innovating abuse deterrent drugs, today announced that on...
Acura Pharmaceuticals Announces Second Quarter 2018 Financial Results
14 août 2018 16h15 HE
|
Acura Pharmaceuticals, Inc.
PALATINE, Ill., Aug. 14, 2018 (GLOBE NEWSWIRE) -- Acura Pharmaceuticals, Inc. (OTCQB: ACUR), a specialty pharmaceutical company innovating abuse deterrent drugs, announced today financial results...
Acura Pharmaceuticals Announces First Quarter 2018 Financial Results
29 juin 2018 16h10 HE
|
Acura Pharmaceuticals, Inc.
PALATINE, Ill., June 29, 2018 (GLOBE NEWSWIRE) -- Acura Pharmaceuticals, Inc. (OTC PINK:ACUR), a specialty pharmaceutical company innovating abuse deterrent drugs, announced today financial results...
Acura Pharmaceuticals Announces Fourth Quarter 2017 and Full Year 2017 Financial Results
07 juin 2018 16h15 HE
|
Acura Pharmaceuticals, Inc.
PALATINE, Ill., June 07, 2018 (GLOBE NEWSWIRE) -- Acura Pharmaceuticals, Inc. (OTC PINK:ACUR), a specialty pharmaceutical company innovating abuse deterrent drugs, announced today financial results...
Acura Pharmaceuticals Announces Successful Results from Study AP-LTX-301
08 janv. 2018 06h00 HE
|
Acura Pharmaceuticals, Inc.
PALATINE, Ill., Jan. 08, 2018 (GLOBE NEWSWIRE) -- Acura Pharmaceuticals, Inc. (OTCQB:ACUR), a specialty pharmaceutical company innovating abuse deterrent drugs, today announced that topline results...
Acura Pharmaceuticals Announces Third Quarter 2017 Financial Results
13 nov. 2017 16h15 HE
|
Acura Pharmaceuticals, Inc.
PALATINE, Ill., Nov. 13, 2017 (GLOBE NEWSWIRE) -- Acura Pharmaceuticals, Inc. (OTCQB:ACUR), a specialty pharmaceutical company innovating abuse deterrent drugs, announced today financial results for...
Acura Pharmaceuticals Advances LTX-03 and its LIMITx™ Technology
09 oct. 2017 06h15 HE
|
Acura Pharmaceuticals, Inc.
PALATINE, Ill., Oct. 09, 2017 (GLOBE NEWSWIRE) -- Acura Pharmaceuticals, Inc. (OTCQB:ACUR), a specialty pharmaceutical company innovating abuse deterrent drugs, today announced that topline results...